Research indicates that in female COPD patients, the expression of estrogen receptors and metabolic genes in lung tissue is increased, suggesting that estrogen levels may promote the progression of COPD by influencing pulmonary immune responses (51–53). The gene discussed is ESR1; the disease is chronic obstructive pulmonary disease.